NCT05791669

Brief Summary

This study was conducted to assess the efficacy of 38% Silver Diamine fluoride and compare it with 5% sodium fluoride varnish in arresting interproximal caries in primary molars at 12 months follow-up. Bitewing radiographs were taken to diagnose as well as to assess caries depth at follow up visits. Each bitewing was scored based on ICCMS radiographic criteria and was compared (follow-ups to baseline)to check for caries arrest. Interproximal caries included in this study, according to ICCMS criteria, were at stages- RA - caries limited to outer half of enamel RA2 - caries limited to the inner half of enamel RA3 - caries limited to outer third of dentine RA4 - caries limited to middle third of dentine

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Aug 2021

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 2, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 8, 2022

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

November 12, 2022

Completed
5 months until next milestone

First Posted

Study publicly available on registry

March 30, 2023

Completed
Last Updated

March 30, 2023

Status Verified

November 1, 2022

Enrollment Period

1 year

First QC Date

November 12, 2022

Last Update Submit

March 17, 2023

Conditions

Keywords

Caries arrest ,interproximal caries, primary molars, SDF

Outcome Measures

Primary Outcomes (1)

  • Caries arrest

    Assessment with bitewing radiographs based on ICCMS radiographic scoring system

    12 months

Study Arms (2)

38% silver diamine fluoride

EXPERIMENTAL
Drug: Silver diamine fluoride

5% sodium fluoride varnish

ACTIVE COMPARATOR
Drug: Sodium fluoride varnish

Interventions

Silver diamine fluoride is a topical medication composed of 25% silver, 5% fluoride, 8% ammonia, and 62% Deionized water, used to treat and prevent dental caries and relieve dentinal hypersensitivity.

Also known as: FAgamin SDF38%
38% silver diamine fluoride

It is a topical application with an active ingredient of 5% sodium fluoride(22,600ppm fluoride).it prolongs the contact time between the fluoride and tooth surface and promotes remineralization and inhibits demineralization.

Also known as: VOCO profluorid varnish
5% sodium fluoride varnish

Eligibility Criteria

Age5 Years - 9 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children aged 5 to 9 years.
  • Presence of at least 2 primary molars with interproximal caries.
  • Carious lesions of enamel or outer or middle third of dentin in primary molars, as assessed by bitewing radiographs with ICCMSTM scoring (RA1, RA2, RA3, RB4).

You may not qualify if:

  • \. Presence of advanced carious lesions reaching inner third of dentin detected by bitewing radiographic examinations ICCMSTM (RC5, RC6).
  • \. Children or adolescents that refuse to participate in the study or present negative behaviours.
  • \. Teeth with premature hypermobility 5. Both physically and mentally disabled children

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Post graduate institute of dental sciences

Rohtak, Haryana, 124001, India

Location

MeSH Terms

Interventions

silver diamine fluorideBifluorid 12

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 12, 2022

First Posted

March 30, 2023

Study Start

August 1, 2021

Primary Completion

August 2, 2022

Study Completion

November 8, 2022

Last Updated

March 30, 2023

Record last verified: 2022-11

Locations